HIGHLIGHTS
- What: The increasing use of SGLT2 inhibitors necessitates a vigilant approach to the diabetic patient with ketoacidosis.
- Who: Alexandria et al. from the Family Medicine, Louisiana State University Health Sciences Center, USA have published the paper: Received 11/22/2024 Review began 11/25/2024 Review ended 12/06/2024 Published 12/09/2024, in the Journal: (JOURNAL) of December/09,/2024
SUMMARY
Diabetic ketoacidosis is a well-established metabolic derangement classically characterized by the triad of hyperglycemia, elevated anion gap metabolic acidosis, and ketonemia. Diabetic ketoacidosis is more commonly seen . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.